Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Concord International Hospital was a private acute hospital in Singapore that operated at 19 Adam Road and provided general medical and surgical care, oncology services, radiation therapy, chemotherapy, diagnostic imaging, laboratory, pharmacy, ICU, and day surgery services. The facility was formerly known as Fortis Colorectal Hospital before being acquired by Concord Medical Services Holdings and renamed Concord International Hospital in 2015. In late 2020, Concord Medical divested the operating entity, and the hospital's services were temporarily suspended by Singapore's Ministry of Health over regulatory lapses. MOH later approved resumption of services in 2021, but the hospital was intended to reopen under a new name and the facility subsequently became Crawfurd Hospital. It was a healthcare delivery asset rather than a biotech or drug-development company and did not have a disclosed therapeutic pipeline in the biotech sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Concord International Hospital.